Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
yea, thanks Bob, strange volume daYS BEFORE..
Yup, time to move on...may work out....but i'm done
Did ya sell Bob? Thx
Hasn't this statement been made couple yrs ago? The COAG potential?
that info was in the IHUB intro
BIAD already has two developed and patented technologies DSR (Digital Strip Reader) and COAG (Blood Coagulation Monitor) ready for commercialization . BIAD is currently in discussions with potential partners for both.
Thanks, Joe. glta
I sent the company an e-mail and they just replied. Glad I bought a bunch at .02 and .026, as nothing's changed other than Sysmex. Big deal .... they were approached by other companies during the Sysmex relationship and they are already on the phone with them, now that they can discuss things. I told the CEO in my e-mail that I predicted months ago that Sysmex would try and steal their IP and my guess is that's exactly what happened. But hey, in the meantime, they at least got paid for being ripped off, at least $1 million.
Lot's of "ask slapping" going on here.........Lol
On a "sell first and ask questions later" day, there's no need whatsoever to slap the ask if you want shares. Just sit on the bid and you'll get all you want because not everyone has seen the news, which really isn't that big of a deal to me, as this product is not the product that BIAD expects the most from. In the meantime, they have plenty of cash and they haven't raised capital in over 5 years. People kept thinking dilution was driving the stock down from .30, but it was the Spaniards who casually sold out and then didn't properly disclose it to the SEC.
I agree!! just added another 100k @ .0275
True, they got that benefit of the 1 Mill
Maybe another company will come along,
I think you need to read the 8-K again, as Sysmex first left a message and then there was a follow-up call in which the two parties spoke. Sysmex did pay BIAD at least $1 million, so I don't think I would compare them with a ChiScam.
Didn't know that it was a "one man show"
anyway to leave a phone message on such a deal, then cancel...not professional
sounds like china deals LOL
Well, shit, my earlier post was not meant to come true. I just looked and saw the drop and 8K. Holy crap!!!
JJSeabrook Member Level Thursday, 04/14/16 09:52:46 AM
Re: dancingblonde post# 1385
Post # of 1398
You may have to move the decimal point over a space to get a really good buy. LOL
It's a one-man show with everyone else working on the outside. I miss calls every day and companies leave me messages. Not sure what's so funny about that ......
"all out folks, lost 85%, a voice message, LMAO"
all out folks, lost 85%, a voice message, LMAO
remember they need to raise cahs also....that will go sub penny most likely
Since no one here knows what killed the stock to begin with over the past few months, I'll tell you. A group of Spaniards sold around 8 million shares and didn't even file with the SEC as was required. Go back a few quarters and you'll see their position in the stock. Look at the most recent company filing and they're no longer there. In the meantime, those dopes in Spain didn't even file with the SEC. LOL. I'm glad they're now out.
telephone voice message, and again on a voice call
Someone knew inside, thats why the damm volume up to this...
Smart money scooping up the cheapies!
IMO!
Added a bunch at .02-.026, as BIAD's best technology isn't even the technology that Sysmex walked away from after paying over $1 million to BIAD. My guess is that Sysmex will steal what they have from BIAD.
Most of us here have already lost 80-90% or more so why sell at this point? If BIAD finds another partner or moves ahead on one of its other lines, the stock could go back to 0.10 or much higher. So i'm keeping the lotto ticket here. If it gets to 0.01 i might even buy more.
Panic selling. Bring it on.
Bad news from BIAD on the 8-K this a.m. But it makes no sense to sell down here. Yes, it may slip further but if cooler heads prevail, this may rise again on other developments. Note the last paragraph about exploring other possible partners.....
From the 8-K:
Item 8.01 Other Events
On December 17, 2014, Bio Alternative Medical Devices Ltd., (“Bio-AMD Ltd.”) a majority owned subsidiary of Bio-AMD Inc., entered into a Master Agreement (the “Agreement”) with Sysmex Corporation (“Sysmex”) to jointly conduct a feasibility study (the “Study”) for the potential development of a medical point-of-care reader device with disposable test strips for PT-INR assays and new future assays in the field of hemostasis (the “Product”) based on the Bio-AMD Ltd. COAG technology.
Bio-AMD Ltd. believes it has successfully completed the Study.
On April 08, 2016 by telephone voice message, and again on a voice call on April 11, 2016, Bio-AMD Ltd. was informed telephonically by Sysmex that the Study and the Product next phase was a “number one priority for Sysmex.” Accordingly, up to and including April 11, 2016, Bio-AMD Ltd. had every reason to believe the Study would proceed into a next phase.
On April 12, 2016, Bio-AMD Ltd., without warning, was informed telephonically by Sysmex that Sysmex was not planning to proceed with the Study. Bio-AMD Ltd. is awaiting written confirmation of Sysmex’s decision and clarification of its reasons to curtail the Product development contemplated by the Agreement.
In light of the foregoing development with Sysmex, Bio-AMD Inc. and Bio-AMD Ltd. are considering different options for its COAG technology. Because we believe that the COAG technology has been considerably advanced during the Project and may now be considered a less risky endeavor, we believe there may be interest from other companies to pursue the COAG technology. Prior to and during the Study, Bio-AMD Ltd. received expressions of interest from more than one party for use of the COAG technology that could not be pursued due to the terms of the Agreement. Bio-AMD Ltd. will now, as a priority, explore those options and attempt to develop other options with a view to gaining another partner to commercialize its COAG technology. No assurance can be given that we will be successful in obtaining a commercialization partner or otherwise being able to obtain value from our COAG technology.
UPDATE: Sysmex is not proceeding with the study
On April 12, 2016, Bio-AMD Ltd., without warning, was informed telephonically by Sysmex that Sysmex was not planning to proceed with the Study. Bio-AMD Ltd. is awaiting written confirmation of Sysmex’s decision and clarification of its reasons to curtail the Product development contemplated by the Agreement.
8-K out....
On December 17, 2014, Bio Alternative Medical Devices Ltd., ("Bio-AMD Ltd.") a majority owned subsidiary of Bio-AMD Inc., entered into a Master Agreement (the "Agreement") with Sysmex Corporation ("Sysmex") to jointly conduct a feasibility study (the "Study") for the potential development of a medical point-of-care reader device with disposable test strips for PT-INR assays and new future assays in the field of hemostasis (the "Product") based on the Bio-AMD Ltd. COAG technology.
Bio-AMD Ltd. believes it has successfully completed the Study.
On April 08, 2016 by telephone voice message, and again on a voice call on April 11, 2016, Bio-AMD Ltd. was informed telephonically by Sysmex that the Study and the Product next phase was a "number one priority for Sysmex." Accordingly, up to and including April 11, 2016, Bio-AMD Ltd. had every reason to believe the Study would proceed into a next phase.
On April 12, 2016, Bio-AMD Ltd., without warning, was informed telephonically by Sysmex that Sysmex was not planning to proceed with the Study. Bio-AMD Ltd. is awaiting written confirmation of Sysmex's decision and clarification of its reasons to curtail the Product development contemplated by the Agreement.
In light of the foregoing development with Sysmex, Bio-AMD Inc. and Bio-AMD Ltd. are considering different options for its COAG technology. Because we believe that the COAG technology has been considerably advanced during the Project and may now be considered a less risky endeavor, we believe there may be interest from other companies to pursue the COAG technology. Prior to and during the Study, Bio-AMD Ltd. received expressions of interest from more than one party for use of the COAG technology that could not be pursued due to the terms of the Agreement. Bio-AMD Ltd. will now, as a priority, explore those options and attempt to develop other options with a view to gaining another partner to commercialize its COAG technology. No assurance can be given that we will be successful in obtaining a commercialization partner or otherwise being able to obtain value from our COAG technology.
https://biz.yahoo.com/e/160414/biad8-k.html
You may have to move the decimal point over a space to get a really good buy. LOL
And here I thought .10 was a fantastic buy. So much for my Warren Buffett impersonation. Holding lots higher, but nevertheless still holding...
"Yes, approaching 4X average volume today. Not a pretty sight around this joint. They could at least send a stripper and a beer by every now and than as we watch our money fade away. LOL"
Haha, that would be nice of them... Maybe it's that gentleman out of CA that filed the 13D?
Yes, approaching 4X average volume today. Not a pretty sight around this joint. They could at least send a stripper and a beer by every now and than as we watch our money fade away. LOL
couple volume days, guess someone got tired holding
Yes, sure am.
Are you still holding Joe ?
yea, its just a dang lotto, in which am under badly
yes, looks like they're still in the running with Sysmex.
Just have to wait (we're getting good at that!) for the real deal to be announced...or not.
Still up in the air as far as I can tell.
I hope it pans out soon croptop... Thanks for the post!!!
was this missed in the reading?
"Our plan for the fiscal year ending 2016 is to continue in our attempts to secure commercial agreements for DSR for pregnancy and other applications, and to progress with the Agreement signed by Sysmex."
thanks joe, always like your insight. I am just a dummy on for the ride if i get lucky. don't understand any of these deals/10k's...LOL
Thanks and keep us informed
Who knows what the MM's are up to? Very hard to see what is going on here at the moment, except that someone exited with a decent size position!! Just had an intense eye surgery earlier in the week and not suppose to be on the computer or bright light... LOL
Good luck to all!!! Still holding more then what was traded yesterday!!!!
As of 21 March there has not been an additional share diluted since the last 10q. Guess I have to retract my last post on this board.
bid under a nickle.
like a coiled spring.
The reaction to the 10K seems to be going well
December 31, 2015 is NOT 15 months ago.
What cracks me up is that absolutely no one has figured out why the stock dropped so much last year. Read the 10-K closely, as the answer is right in front of your eyes. In fact, it was right in front of your eyes last quarter. I'll give you guys a day to try and figure out the puzzle and then I'll solve it for you.
Subsequent to December 31, 2015, the Study has been successfully completed and the results presented to Sysmex which is now clarifying the plan for the next phase of development. There can be no assurance that Sysmex will enter into additional agreements to jointly develop with us the Products or that such a manufacturing/license agreement will ever be consummated or that the Products will ever be commercially sold by Sysmex.
Like I just said, 15 months ago was when the development agreement began. That's not when any results took place like you said. The agreement lasts 27 months and consists of more than one phase as you imply. It ain't rocket science.
Followers
|
42
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1616
|
Created
|
10/19/08
|
Type
|
Free
|
Moderators |
Share Structure
Market Value1 $4,879,856 a/o March 28,2013
Shares Outstanding 44,525,966 a/o March 18, 2013
Float 37,000,000 of which 15,000,000 are paper certs.
Authorized Shares 500,000,000
Action Stock Transfer Corporation
2469 E. Fort Union Blvd., Suite 214
Salt Lake City, UT 84121
Note: This is a non dilutive company!!! The share structure has been unchanged for the past 3 years.
Contact details
Bio-Alternative Medical Devices Ltd
Daresbury Science & Innovation Campus
Daresbury Innovation Centre
Keckwick Lane
Daresbury
Cheshire
WA4 4FS United Kingdom
Tel: +44 (0) 1925 606 471
Fax: +44 (0) 1925 606 475
Web site: http://www.bioamd.com
Daily Chart:BIAD
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |